91 related articles for article (PubMed ID: 6742031)
1. Long-term suppression of hypermenorrhea by progesterone intrauterine contraceptive devices.
Parmer J
Am J Obstet Gynecol; 1984 Jul; 149(5):578-9. PubMed ID: 6742031
[TBL] [Abstract][Full Text] [Related]
2. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
3. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2000; (2):CD002126. PubMed ID: 10796865
[TBL] [Abstract][Full Text] [Related]
4. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with the uterine progesterone system (Progestasert R).
Zador G; Nilsson BA; Nilsson B; Sjöberg NO; Weström L; Wiese J
Contraception; 1976 May; 13(5):559-69. PubMed ID: 1261259
[TBL] [Abstract][Full Text] [Related]
6. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
Custo GM; Cosmi EV
Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
[TBL] [Abstract][Full Text] [Related]
7. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
8. Treatment of menorrhagia with intrauterine release of progesterone.
Bergqvist A; Rybo G
Br J Obstet Gynaecol; 1983 Mar; 90(3):255-8. PubMed ID: 6830732
[TBL] [Abstract][Full Text] [Related]
9. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
10. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
11. Effects of the Progestasert on the menstrual pattern, ovarian steroids and endometrium.
Wan LS; Hsu YC; Ganguly M; Bigelow B
Contraception; 1977 Oct; 16(4):417-34. PubMed ID: 923252
[TBL] [Abstract][Full Text] [Related]
12. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
Milsom I; Andersson K; Andersch B; Rybo G
Am J Obstet Gynecol; 1991 Mar; 164(3):879-83. PubMed ID: 1900665
[TBL] [Abstract][Full Text] [Related]
13. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
14. Selected events following insertion of the Progestasert system.
Gibor Y; Mitchell C
Contraception; 1980 May; 21(5):491-503. PubMed ID: 7428359
[TBL] [Abstract][Full Text] [Related]
15. Hormonal evaluation of the intrauterine progesterone contraceptive system.
Bryand-Greenwood GD; Greenwood FC; Hale RW; Morishige WK
J Clin Endocrinol Metab; 1977 Apr; 44(4):721-7. PubMed ID: 849982
[TBL] [Abstract][Full Text] [Related]
16. [Management of abnormal bleeding in an intrauterine device user].
Desmons F; Adam-steen C
Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of U-coil progesterone releasing device versus inert U-coil IUD.
Serour GI; Hamza A; El Sheikha Z; Hefnawi FI
Popul Sci; 1982; (3):121-35. PubMed ID: 12266213
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive overview of intrauterine contraceptive device (IUCD).
Nnatu S
J Obstet Gynaecol East Cent Africa; 1983 Sep; 2(3):91-6. PubMed ID: 12340192
[TBL] [Abstract][Full Text] [Related]
19. The levonorgestrel-releasing intrauterine device.
Toivonen J
Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
[TBL] [Abstract][Full Text] [Related]
20. Intrauterine progesterone contraceptive system as an alternative in cases where conventional IUD's are unsuitable.
Ylöstalo P; Rantakylä P; Järvinen PA; Kauppila E
Acta Obstet Gynecol Scand; 1979; 58(3):279-81. PubMed ID: 573535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
